CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-15 | Schinazi Raymond F Director | Purchase | +2,941,176 | $0.51 | $1.5M | 275,520,853 |
| 2016-03-15 | HSIAO JANE PH D Director | Purchase | +1,235,294 | $0.51 | $630K | 3,435,294 |
| 2015-12-23 | Meckler Jeffrey A CHIEF EXECUTIVE OFFICER | Purchase | +100,000 | $0.58 | $58K | 363,043 |
| 2015-11-24 | Dale Curtis INTERIM CFO | Grant or award · Stock options (Right to Buy) | +100,000 | 100,000 | ||
| 2015-10-01 | Meckler Jeffrey A CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +16,000,000 | 16,000,000 | ||
| 2015-10-01 | Mayers Douglas L CHIEF MEDICAL OFFICER | Grant or award · Stock Options (Right to buy) | +2,400,000 | 2,400,000 | ||
| 2015-07-21 | Linscott Walt Addison GENERAL COUNSEL AND SECRETARY | Grant or award · Stock options (right to buy) | +1,200,000 | 1,200,000 | ||
| 2015-04-21 | Schinazi Raymond F Director | Purchase | +3,464,855 | $0.92 | $3.2M | 272,579,677 |
| 2015-04-13 | Schinazi Raymond F Director | Grant or award · Stock options (Right to buy) | +350,000 | 350,000 | ||
| 2015-04-13 | HSIAO JANE PH D Director | Grant or award · Stock options (Right to buy) | +350,000 | 350,000 | ||
| 2015-04-13 | FROST PHILLIP MD ET AL Director | Grant or award · Stock options (Right to buy) | +350,000 | 350,000 | ||
| 2015-04-13 | Rubin Steven D Director | Grant or award · Stock options (Right to buy) | +350,000 | 350,000 | ||
| 2015-04-13 | BLOCK DAVID S Director | Grant or award · Stock options (Right to buy) | +350,000 | 350,000 | ||
| 2015-04-13 | McGuire Gerald A CHIEF FINANCIAL OFFICER | Grant or award · Stock options (Right to buy) | +200,000 | 200,000 | ||
| 2015-03-25 | FROST PHILLIP MD ET AL Director | Purchase | +3,464,855 | $0.92 | $3.2M | 103,558,969 |
| 2015-03-25 | BLOCK DAVID S Director | Purchase | +108,696 | $0.92 | $100K | 108,696 |
| 2015-03-25 | Rubin Steven D Director | Purchase | +54,348 | $0.92 | $50K | 694,268 |
| 2015-03-25 | WILCOX GARY CHIEF EXECUTIVE OFFICER | Purchase | +54,348 | $0.92 | $50K | 16,889,585 |
| 2015-03-25 | HSIAO JANE PH D Director | Purchase | +2,200,000 | $0.92 | $2.0M | 2,200,000 |
| 2015-03-25 | Meckler Jeffrey A Director | Purchase | +163,043 | $0.92 | $150K | 263,043 |
Page 6 of 8 · 145 trades